$CYAN
CYANOTECH CORP

2022 Q1 Form 10-Q Financial Statement

#000143774922002997 Filed on February 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q3
Revenue $8.126M $9.459M $9.419M
YoY Change -13.9% 35.42% 9.89%
Cost Of Revenue $5.232M $6.221M $5.657M
YoY Change -21.54% 26.6% 7.34%
Gross Profit $2.894M $3.238M $3.762M
YoY Change 4.44% 56.35% 13.97%
Gross Profit Margin 35.61% 34.23% 39.94%
Selling, General & Admin $2.301M $2.530M $2.553M
YoY Change -13.98% 9.95% -10.3%
% of Gross Profit 79.51% 78.13% 67.86%
Research & Development $229.0K $200.0K $127.0K
YoY Change 90.83% -5.21% -26.59%
% of Gross Profit 7.91% 6.18% 3.38%
Depreciation & Amortization $397.0K $404.0K $398.0K
YoY Change -2.7% -4.49% -11.75%
% of Gross Profit 13.72% 12.48% 10.58%
Operating Expenses $2.530M $2.730M $2.680M
YoY Change -9.48% 8.68% -11.23%
Operating Profit $364.0K $508.0K $1.082M
YoY Change -1616.67% -215.19% 283.69%
Interest Expense -$80.00K $116.0K $101.0K
YoY Change -54.55% -5.69% -16.53%
% of Operating Profit -21.98% 22.83% 9.33%
Other Income/Expense, Net
YoY Change
Pretax Income $284.0K $392.0K $981.0K
YoY Change -241.29% -52.48% 509.32%
Income Tax $7.000K $6.000K $11.00K
% Of Pretax Income 2.46% 1.53% 1.12%
Net Earnings $277.0K $386.0K $970.0K
YoY Change -238.5% -53.33% 525.81%
Net Earnings / Revenue 3.41% 4.08% 10.3%
Basic Earnings Per Share $0.06 $0.16
Diluted Earnings Per Share $44.71K $0.06 $0.15
COMMON SHARES
Basic Shares Outstanding 6.194M 6.183M 6.130M
Diluted Shares Outstanding 6.371M 6.315M

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.589M $2.298M $2.134M
YoY Change -31.27% -30.78% -49.79%
Cash & Equivalents $2.589M $2.298M $2.134M
Short-Term Investments
Other Short-Term Assets $545.0K $293.0K $339.0K
YoY Change 11.68% -31.86% -21.16%
Inventory $9.466M $8.724M $9.808M
Prepaid Expenses
Receivables $3.664M $4.526M $3.077M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $16.26M $15.84M $15.36M
YoY Change 7.67% 5.44% -8.82%
LONG-TERM ASSETS
Property, Plant & Equipment $11.89M $11.94M $11.90M
YoY Change -2.07% -3.45% -5.47%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $109.0K $112.0K $118.0K
YoY Change -9.17% -13.18% -16.9%
Total Long-Term Assets $15.78M $15.46M $15.52M
YoY Change 0.05% -3.92% -5.43%
TOTAL ASSETS
Total Short-Term Assets $16.26M $15.84M $15.36M
Total Long-Term Assets $15.78M $15.46M $15.52M
Total Assets $32.05M $31.30M $30.88M
YoY Change 3.78% 0.6% -7.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.362M $2.275M $1.833M
YoY Change 3.28% 46.77% -20.3%
Accrued Expenses $1.412M $1.291M $1.250M
YoY Change 0.0% 84.17% 27.81%
Deferred Revenue $164.0K $83.00K $110.0K
YoY Change 32.26% -28.45% -44.44%
Short-Term Debt $0.00 $0.00 $350.0K
YoY Change -100.0% -100.0% -82.5%
Long-Term Debt Due $490.0K $626.0K $1.081M
YoY Change -77.83% -84.17% -74.24%
Total Short-Term Liabilities $4.821M $4.657M $4.647M
YoY Change -16.99% -30.06% -41.96%
LONG-TERM LIABILITIES
Long-Term Debt $4.336M $4.400M $4.468M
YoY Change -10.1% 10.06% -19.5%
Other Long-Term Liabilities $15.00K $20.00K $24.00K
YoY Change -53.13% -41.18% -35.14%
Total Long-Term Liabilities $4.351M $4.420M $4.492M
YoY Change -10.38% 9.62% -19.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.821M $4.657M $4.647M
Total Long-Term Liabilities $4.351M $4.420M $4.492M
Total Liabilities $12.56M $12.10M $12.26M
YoY Change -9.25% -13.27% -27.61%
SHAREHOLDERS EQUITY
Retained Earnings -$14.19M -$14.47M -$14.86M
YoY Change -13.18% -10.38% -12.48%
Common Stock $124.0K $124.0K $123.0K
YoY Change 1.64% 1.64% 0.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.49M $19.20M $18.61M
YoY Change
Total Liabilities & Shareholders Equity $32.05M $31.30M $30.88M
YoY Change 3.78% 0.6% -7.15%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q3
OPERATING ACTIVITIES
Net Income $277.0K $386.0K $970.0K
YoY Change -238.5% -53.33% 525.81%
Depreciation, Depletion And Amortization $397.0K $404.0K $398.0K
YoY Change -2.7% -4.49% -11.75%
Cash From Operating Activities $1.035M $918.0K $2.284M
YoY Change -30.07% -517.27% 77.05%
INVESTING ACTIVITIES
Capital Expenditures -$525.0K -$224.0K -$350.0K
YoY Change 191.67% -20.0% 105.88%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$525.0K -$224.0K -$350.0K
YoY Change 191.67% -20.0% 105.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -219.0K -530.0K -861.0K
YoY Change -74.53% 26.19% 330.5%
NET CHANGE
Cash From Operating Activities 1.035M 918.0K 2.284M
Cash From Investing Activities -525.0K -224.0K -350.0K
Cash From Financing Activities -219.0K -530.0K -861.0K
Net Change In Cash 291.0K 164.0K 1.073M
YoY Change -33.86% -117.83% 16.63%
FREE CASH FLOW
Cash From Operating Activities $1.035M $918.0K $2.284M
Capital Expenditures -$525.0K -$224.0K -$350.0K
Free Cash Flow $1.560M $1.142M $2.634M
YoY Change -6.02% 1803.33% 80.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6194166
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
156000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
32000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
293000 USD
CY2020Q4 cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
0 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
8415000 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6194166
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6194166
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6116073
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6116073
cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
0 USD
cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
0 USD
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
445000 USD
CY2020Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2298000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3767000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4526000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2436000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
8724000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
488000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
15841000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
15106000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11936000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12136000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3412000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3517000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
112000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
120000 USD
CY2021Q4 us-gaap Assets
Assets
31301000 USD
CY2021Q1 us-gaap Assets
Assets
30879000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2275000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2287000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1291000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
844000 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
83000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
124000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
382000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
343000 USD
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30879000 USD
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9459000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6985000 USD
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1403000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27842000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22907000 USD
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6221000 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4914000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17170000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
33544000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
33267000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14471000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16348000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
19197000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
17041000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31301000 USD
CY2021Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1000000 USD
CY2021Q4 cyan Longterm Debt Current Maturities Excluding Line Of Credit Current
LongtermDebtCurrentMaturitiesExcludingLineOfCreditCurrent
626000 USD
CY2021Q1 cyan Longterm Debt Current Maturities Excluding Line Of Credit Current
LongtermDebtCurrentMaturitiesExcludingLineOfCreditCurrent
1210000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4657000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5808000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4400000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4823000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3027000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3175000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
12104000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
13838000 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
124000 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
122000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14560000 USD
CY2021Q4 us-gaap Gross Profit
GrossProfit
3238000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
2071000 USD
us-gaap Gross Profit
GrossProfit
10672000 USD
us-gaap Gross Profit
GrossProfit
8347000 USD
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1001000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4171000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3801000 USD
CY2021Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1127000 USD
CY2020Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1300000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3808000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3918000 USD
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
200000 USD
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
211000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
483000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
519000 USD
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
2730000 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
2512000 USD
us-gaap Operating Expenses
OperatingExpenses
8462000 USD
us-gaap Operating Expenses
OperatingExpenses
8238000 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
508000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-441000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
2210000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
109000 USD
CY2021Q4 us-gaap Interest Expense
InterestExpense
116000 USD
CY2020Q4 us-gaap Interest Expense
InterestExpense
123000 USD
us-gaap Interest Expense
InterestExpense
312000 USD
us-gaap Interest Expense
InterestExpense
374000 USD
CY2021Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1389000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1389000 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
392000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
825000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1898000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1124000 USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
386000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
827000 USD
us-gaap Net Income Loss
NetIncomeLoss
1877000 USD
us-gaap Net Income Loss
NetIncomeLoss
1121000 USD
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6183000
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6097000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6144000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6060000
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6371000
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6222000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6219000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6169000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
18613000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
386000 USD
CY2021Q4 cyan Stock Issued During Period Value Director Stockgrants
StockIssuedDuringPeriodValueDirectorStockgrants
158000 USD
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
19197000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
16312000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
827000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
17157000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
17041000 USD
cyan Stock Issued During Period Value Director Stockgrants
StockIssuedDuringPeriodValueDirectorStockgrants
158000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-39000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
-0 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
160000 USD
us-gaap Net Income Loss
NetIncomeLoss
1877000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
19197000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
15846000 USD
cyan Stock Issued During Period Value Director Stockgrants
StockIssuedDuringPeriodValueDirectorStockgrants
158000 USD
cyan Adjustments To Additional Paid In Capital Settlement Agreement With A Former Executive
AdjustmentsToAdditionalPaidInCapitalSettlementAgreementWithAFormerExecutive
-0 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-6000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
-0 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
38000 USD
us-gaap Net Income Loss
NetIncomeLoss
1121000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
17157000 USD
us-gaap Net Income Loss
NetIncomeLoss
1877000 USD
us-gaap Net Income Loss
NetIncomeLoss
1121000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1202000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1340000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1389000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
45000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
73000 USD
cyan Operating Lease Rightofuse Asset Amortization
OperatingLeaseRightofuseAssetAmortization
232000 USD
cyan Operating Lease Rightofuse Asset Amortization
OperatingLeaseRightofuseAssetAmortization
236000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
318000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
196000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
124000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
31000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2214000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-441000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
309000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-64000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-180000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-78000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-269000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-665000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
447000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-140000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-41000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-211000 USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-236000 USD
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-236000 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-12000 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-20000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1344000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
919000 USD
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
745000 USD
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
583000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-745000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-583000 USD
cyan Repayments Of Short Term Contractual Obligation
RepaymentsOfShortTermContractualObligation
-0 USD
cyan Repayments Of Short Term Contractual Obligation
RepaymentsOfShortTermContractualObligation
38000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1000000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
250000 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
500000 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
-0 USD
us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
14000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2298000 USD
CY2021Q4 cyan Working Capital Deficit
WorkingCapitalDeficit
11186000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3767000 USD
CY2021Q1 cyan Working Capital Deficit
WorkingCapitalDeficit
9298000 USD
CY2021Q4 cyan Long Term Debt And Capital Lease Obligations Current And Noncurrent
LongTermDebtAndCapitalLeaseObligationsCurrentAndNoncurrent
4111000 USD
us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
1381000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
529000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
498000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
-0 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
20000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
39000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2068000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
569000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1469000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
905000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3767000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2417000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2298000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3322000 USD
us-gaap Interest Paid Net
InterestPaidNet
268000 USD
us-gaap Interest Paid Net
InterestPaidNet
344000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Use of Estimates</b></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 54pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosures of any contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the periods reported.  Management reviews these estimates and assumptions periodically and reflects the effect of revisions in the period that they are determined to be necessary.  Actual results could differ from those estimates and assumptions.</p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p>
CY2020Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
55000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
251000 USD
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9459000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6985000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27842000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Concentration Risk</b></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 54pt;">A significant portion of revenue and accounts receivable are derived from a few major customers. For the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> December 31, 2021, </em><span style="-sec-ix-hidden:c80273941">two</span> customers individually accounted for 22% and 21% of the Company’s total net sales, and for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> December 31, 2020, </em><span style="-sec-ix-hidden:c80273945">two</span> customers individually accounted for 18% and 19% of the Company’s total net sales. For the <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> December 31, 2021, </em><span style="-sec-ix-hidden:c80273949">two</span> customers individually accounted for 21% and 18% of the Company’s total net sales, and for the <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> December 31, 2020, </em><span style="-sec-ix-hidden:c80273953">two</span> customers individually accounted for 17% each of the Company’s total net sales. Two customers accounted for 67% of the Company’s accounts receivable balance as of <em style="font: inherit;"> December 31, 2021, </em>and <span style="-sec-ix-hidden:c80273956">three</span> customers accounted for 57% of the Company’s accounts receivable balance as of <em style="font: inherit;"> March 31, 2021.</em></p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"> </p>
CY2021Q4 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22907000 USD
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1399000 USD
CY2021Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
547000 USD
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3273000 USD
CY2021Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3206000 USD
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3743000 USD
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4423000 USD
CY2021Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
309000 USD
CY2021Q1 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
239000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
8724000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
8415000 USD
CY2021Q4 cyan Inventory Abnormal Production Costs
InventoryAbnormalProductionCosts
0 USD
CY2021Q4 cyan Non Inventoriable Fixed Costs
NonInventoriableFixedCosts
76000 USD
CY2020Q4 cyan Non Inventoriable Fixed Costs
NonInventoriableFixedCosts
79000 USD
cyan Non Inventoriable Fixed Costs
NonInventoriableFixedCosts
113000 USD
cyan Non Inventoriable Fixed Costs
NonInventoriableFixedCosts
124000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
35255000 USD
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34131000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
23942000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22740000 USD
CY2021Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
623000 USD
CY2021Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
745000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11936000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12136000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2021Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
404000 USD
CY2020Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
423000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1202000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1340000 USD
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
119000 USD
CY2021Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
140000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
322000 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
626000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
2210000 USD
CY2021Q4 cyan Longterm Debt Gross Excluding Current Maturities
LongtermDebtGrossExcludingCurrentMaturities
4519000 USD
CY2021Q1 cyan Longterm Debt Gross Excluding Current Maturities
LongtermDebtGrossExcludingCurrentMaturities
4963000 USD
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
119000 USD
CY2021Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
140000 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4400000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4823000 USD
CY2015Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
500000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
243000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
477000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1289000 USD
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
306000 USD
CY2021Q4 cyan Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
2508000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
5145000 USD
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P13Y
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.074 pure
us-gaap Operating Lease Expense
OperatingLeaseExpense
445000 USD
CY2021Q4 cyan Operating Lease Rightofuse Asset Before Accumulated Amortization
OperatingLeaseRightofuseAssetBeforeAccumulatedAmortization
4255000 USD
CY2021Q1 cyan Operating Lease Rightofuse Asset Before Accumulated Amortization
OperatingLeaseRightofuseAssetBeforeAccumulatedAmortization
4128000 USD
CY2021Q4 cyan Operating Lease Rightofuse Asset Accumulated Amortization
OperatingLeaseRightofuseAssetAccumulatedAmortization
843000 USD
CY2021Q1 cyan Operating Lease Rightofuse Asset Accumulated Amortization
OperatingLeaseRightofuseAssetAccumulatedAmortization
611000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3412000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3517000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
382000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
343000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3027000 USD
CY2021Q4 cyan Number Of Shareholder Approved Sharebased Compensation Plans
NumberOfShareholderApprovedSharebasedCompensationPlans
2 pure
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3175000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3409000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3518000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
464000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
396000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
396000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
374000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
362000 USD
CY2021Q4 cyan Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
3299000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5291000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1882000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
3409000 USD
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
521000 USD
CY2021Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
211000 USD
CY2021Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
399000 USD
CY2021Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
408000 USD
CY2021Q4 cyan Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
184000 USD
CY2021Q1 cyan Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
86000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
187000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
139000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1291000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
844000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
1950000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1280816
CY2021Q4 cyan Sharebased Compensation Arrangement By Sharebased Payment Award Number Of Shares Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardNumberOfSharesOutstanding
283674
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
374300
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.64
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
129700 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
50000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.96
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.95
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
166800
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3.84
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
254500
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.36
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M12D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
135600 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
112833
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.37
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y1M6D
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
39183 USD
CY2021Q4 us-gaap Share Price
SharePrice
3.24
CY2021Q1 us-gaap Share Price
SharePrice
3.30
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
125000
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.19
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
50000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.60
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
33333
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.20
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
141667
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.33
cyan Sharebased Compensation Arrangement By Share Based Payment Award Weighted Average Grant Date Fair Value Optionsgranted
SharebasedCompensationArrangementByShareBasedPaymentAwardWeightedAverageGrantDateFairValueOptionsgranted
79000 USD
CY2021Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.015 pure
CY2020Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.002 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.011 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.003 pure
CY2021Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2017Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
386000 USD
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6183000
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2021Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
188000
CY2021Q4 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
386000 USD
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6371000
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
827000 USD
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6097000
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2020Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
125000
CY2020Q4 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
827000 USD
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6222000
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Net Income Loss
NetIncomeLoss
1877000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6144000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
75000
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
1877000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6219000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
us-gaap Net Income Loss
NetIncomeLoss
1121000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6060000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
109000
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
1121000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6169000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18

Files In Submission

Name View Source Status
0001437749-22-002997-index-headers.html Edgar Link pending
0001437749-22-002997-index.html Edgar Link pending
0001437749-22-002997.txt Edgar Link pending
0001437749-22-002997-xbrl.zip Edgar Link pending
cyan-20211231.xsd Edgar Link pending
cyan-20211231_cal.xml Edgar Link unprocessable
cyan-20211231_def.xml Edgar Link unprocessable
cyan-20211231_lab.xml Edgar Link unprocessable
cyan-20211231_pre.xml Edgar Link unprocessable
cyan20211231_10q.htm Edgar Link pending
cyan20211231_10q_htm.xml Edgar Link completed
ex_331128.htm Edgar Link pending
ex_331129.htm Edgar Link pending
ex_331130.htm Edgar Link pending
ex_331131.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
logo.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending